Literature DB >> 8269392

Antifungal susceptibility testing.

J H Rex1, M A Pfaller, M G Rinaldi, A Polak, J N Galgiani.   

Abstract

Unlike antibacterial susceptibility testing, reliable antifungal susceptibility testing is still largely in its infancy. Many methods have been described, but they produce widely discrepant results unless such factors as pH, inoculum size, medium formulation, incubation time, and incubation temperature are carefully controlled. Even when laboratories agree upon a common method, interlaboratory agreement may be poor. As a result of numerous collaborative projects carried out both independently and under the aegis of the Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards, the effects of varying these factors have been extensively studied and a standard method which minimizes interlaboratory variability during the testing of Candida spp. and Cryptococcus neoformans has been proposed. This review summarizes this work, reviews the strengths and weaknesses of the proposed susceptibility testing standard, and identifies directions for future work.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8269392      PMCID: PMC358294          DOI: 10.1128/CMR.6.4.367

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  119 in total

1.  THE DETERMINATION OF SULFONAMIDE SUSCEPTIBILITY OF BACTERIA.

Authors:  A W BAUER; J C SHERRIS
Journal:  Chemotherapia (Basel)       Date:  1964

2.  Fatal septicemia due to amphotericin B-resistant Candida lusitaniae.

Authors:  R Guinet; J Chanas; A Goullier; G Bonnefoy; P Ambroise-Thomas
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

3.  In-vitro resistance to imidazole antifungals in Candida albicans.

Authors:  E M Johnson; M D Richardson; D W Warnock
Journal:  J Antimicrob Chemother       Date:  1984-06       Impact factor: 5.790

4.  Azole resistance in Candida albicans.

Authors:  J F Ryley; R G Wilson; K J Barrett-Bee
Journal:  Sabouraudia       Date:  1984

5.  [Correlation of in vitro and in vivo actions of azole antimycotics].

Authors:  M Plempel
Journal:  Mykosen       Date:  1984-01

6.  Susceptibility testing of filamentous fungi to amphotericin B by a rapid radiometric method.

Authors:  W G Merz; D Fay; B Thumar; D Dixon
Journal:  J Clin Microbiol       Date:  1984-01       Impact factor: 5.948

7.  Relative inhibition factors--a novel approach to the assessment of antifungal antibiotics in vitro.

Authors:  F C Odds; A B Abbott
Journal:  J Antimicrob Chemother       Date:  1984-01       Impact factor: 5.790

8.  Antimycotic efficacy of bifonazole in vitro and in vivo.

Authors:  M Plempel; E Regel; K H Büchel
Journal:  Arzneimittelforschung       Date:  1983

9.  Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors.

Authors:  P C Taylor; F D Schoenknecht; J C Sherris; E C Linner
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

10.  Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model.

Authors:  R L Stiller; J E Bennett; H J Scholer; M Wall; A Polak; D A Stevens
Journal:  J Infect Dis       Date:  1983-06       Impact factor: 5.226

View more
  98 in total

1.  Comparative study of agar diffusion test and the NCCLS macrobroth method for in vitro susceptibility testing of Candida spp.

Authors:  L M Soni; M N Burattini; A C Pignatari; O F Gompertz; A L Colombo
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

Review 2.  Mechanisms of fungal resistance: an overview.

Authors:  Maher M Balkis; Steven D Leidich; Pranab K Mukherjee; Mahmoud A Ghannoum
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Antifungal susceptibility testing of fluconazole by flow cytometry correlates with clinical outcome.

Authors:  C Wenisch; C B Moore; R Krause; E Presterl; P Pichna; D W Denning
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

Review 4.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

5.  Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group.

Authors:  P Phillips; S Shafran; G Garber; C Rotstein; F Smaill; I Fong; I Salit; M Miller; K Williams; J M Conly; J Singer; S Ioannou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

6.  Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts.

Authors:  B A Arthington-Skaggs; M Motley; D W Warnock; C J Morrison
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

7.  Assessment of the effect of amphotericin B on the vitality of Candida albicans.

Authors:  R S Liao; R P Rennie; J A Talbot
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

8.  Rapid flow cytometric susceptibility testing of Candida albicans.

Authors:  R Ramani; A Ramani; S J Wong
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

9.  Comparative evaluation of a new fluorescent carboxyfluorescein diacetate-modified microdilution method for antifungal susceptibility testing of Candida albicans isolates.

Authors:  Robert S Liao; Robert P Rennie; James A Talbot
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

10.  In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.

Authors:  F Barchiesi; A L Colombo; D A McGough; A W Fothergill; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.